US Ditches Global Progress: "Monkeypox" Name Returns After Backlash Over Racist Label

US Reverts to "Monkeypox" Name After Global Shift Away from Racist Label In a move that has sparked controversy among global health officials, the US Centers for Disease Control and Prevention (CDC) under the Trump administration has switched back to using the outdated name "monkeypox" to refer to the disease caused by Orthopoxvirus monkeypox. This decision comes after the world abandoned the term in 2022 due to its racist and stigmatizing connotations. The CDC's change of heart follows a long-standing global effort to rebrand the disease with a more neutral name, "mpox." The World Health Organization (WHO) had declared international public health emergencies in 2022 and 2024 due to the rapid spread of mpox. As the virus gained attention, health officials began to scrutinize the problematic name. According to Dr. Maria Van Kerkhove, a leading expert on mpox at the WHO, "The name 'monkeypox' was always a misnomer. We now know that the virus can infect a wide range of animals, not just monkeys." She added, "Using this outdated name perpetuates stigma and misinformation about the disease." The origins of the name date back to 1958 when scientists discovered the virus in captive Asian monkeys shipped from Singapore to Denmark. Initially, it was assumed that monkeys were the natural hosts for the virus. However, subsequent studies revealed that humans and other animals can also contract the disease. In an effort to promote accurate information and reduce stigma, health experts emphasize the importance of using the preferred term "mpox." Dr. Van Kerkhove stressed, "Using the correct name is crucial in preventing misinformation and ensuring that people understand the risks associated with mpox." As the US CDC reverts to the outdated name, global health officials are urging caution and emphasizing the need for accurate communication about the disease. The WHO continues to recommend using the term "mpox" to avoid perpetuating stigma. In a statement, the CDC acknowledged the change but did not provide further explanation. As the situation unfolds, it is essential for individuals to consult reputable sources and healthcare professionals for information on mpox prevention and treatment. Background: Mpox has been a global health concern since 2022, with widespread outbreaks reported in various countries. The disease causes symptoms such as fever, rash, and lesions, which can be severe in some cases. According to the WHO, there have been over 50,000 reported cases of mpox worldwide. Additional Perspectives: Dr. Anthony Fauci, a leading expert on infectious diseases, expressed concern about the CDC's decision, stating, "Using an outdated name like 'monkeypox' can create confusion and undermine efforts to control the spread of the disease." In contrast, some critics argue that the change is minor and does not significantly impact public health efforts. However, many experts agree that using accurate and neutral language is essential in promoting understanding and reducing stigma. Current Status: The US CDC's decision has sparked controversy among global health officials, who are urging caution and emphasizing the need for accurate communication about mpox. As the situation unfolds, it is essential for individuals to consult reputable sources and healthcare professionals for information on mpox prevention and treatment. In conclusion, the US CDC's switch back to "monkeypox" highlights the ongoing challenges in accurately communicating about diseases with stigmatizing names. By promoting education and awareness, we can work towards a more informed and empathetic approach to public health. *Reporting by Arstechnica.*